The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.

项目摘要/摘要： 加大努力改善资源匮乏国家癌症的早期发现、诊断和治疗 导致了癌症存活率的适度改善，并导致了癌症人口的增加 幸存者。然而，在资源匮乏的国家，人们对癌症存活率的理解存在差距。这个 这项建议的目标是测量患有卡波西的癌症幸存者的健康相关生活质量(HRQOL) 在马拉维，肉瘤(KS)和淋巴瘤贯穿于癌症治疗的整个过程。符合NCI对 癌症幸存者，我们的幸存者群体包括任何从 通过生命的平衡来诊断。我们假设：a)KS和淋巴瘤幸存者将有差异 HRQL的心理健康和生理功能领域在前(前)、中(中)和后1年 (后)癌症指导治疗；以及b)治疗后HRQL在短期(&lt； 治疗完成后1年)、中期(≥治疗完成后1-5年)或长期(&gt；5 治疗完成后一年)幸存者。

PROJECT SUMMARY/ABSTRACT: Increasing efforts to improve early detection, diagnosis, and treatment of cancers in low resourced countries have led to modest improvements in cancer survival and given rise to an expanding population of cancer survivors. However, there is a gap in the understanding of cancer survivorship in low resourced countries. The goal of this proposal is to measure health-related quality of life (HRQoL) for cancer survivors with Kaposi sarcoma (KS) and lymphoma across the continuum of cancer care in Malawi. In line with NCI's definition of a cancer survivor, our survivor population includes any individual diagnosed with cancer from the time of diagnosis through the balance of life. We hypothesize that: a) KS and lymphoma survivors will have differences in mental health and physical function domains of HRQoL before (pre-), during (mid-), and up to 1 year after (post-) cancer-directed treatment; and b) there is no difference in post-treatment HRQoL among short-term (< 1 year since treatment completion), medium-term (≥1-5 years since treatment completion) or long-term (> 5 year since treatment completion) survivors.